Share this postπ LEMMING INVESTOR RESEARCH by πSmall Company ChampionPoolbeg Pharma PlcCopy linkFacebookEmailNotesMorePoolbeg Pharma PlcImmunomodulator I Patent Opposition to be Withdrawnπ Elric LangtonSep 19, 2023β PaidShare this postπ LEMMING INVESTOR RESEARCH by πSmall Company ChampionPoolbeg Pharma PlcCopy linkFacebookEmailNotesMoreShareBy Elric Langton | 19 September 2023I have a financial interest in Poolbeg Pharma.Poolbeg Pharma (AIM: POLB, OTCQB: POLBF), a clinical-stage biopharmaceutical company specialising in addressing diseaβ¦This post is for paid subscribersSubscribeAlready a paid subscriber? Sign inPreviousNext